1007-385X
2015 Issue 1
MicroRNAs in the management of hepatocellular carcinoma: New opportunities and challenges
Hou Jin;Cao Xuetao;National Key Laboratory of Medical Immunology & Institute of Immunology;Second Military Medical University;
Hou Jin;Cao Xuetao;National Key Laboratory of Medical Immunology & Institute of Immunology;Second Military Medical University;
..............page:1-7
Quality management and outcome evaluation of cellular immunotherapy of cancer
Zhang Bin;Chen Hu;Tumor Biotherapy Center & Department of Hematopoietic Stem Cell Transplantation;Institute of Hematopoietic Stem Cell of PLA;307th Hospital of PLA;
Zhang Bin;Chen Hu;Tumor Biotherapy Center & Department of Hematopoietic Stem Cell Transplantation;Institute of Hematopoietic Stem Cell of PLA;307th Hospital of PLA;
..............page:8-15
Anti-tumor effects of a dual cancer-specific oncolytic adenovirus carried Apoptin and PEG3 promoter on colorectal cancer in vitro and in vivo
Chen Zhifei;Li Yiquan;Hu Ningning;Lan Tian;Zhou Ye;Li Xiao;Sun Lili;Jin Ningyi;Department of Preventive Veterinary Medicine;College of Veterinary Medicine;Jilin University;Department of Virus;Institute of Military Veterinary Medicine;Academy of Military Medical Sciences;Department of Laboratory Medicine;Changchun University of Chinese Medicine-Affiliated Hospital;No.1 Department of Head and Neck Surgery;Tumor Hospital of Jilin Province;
Chen Zhifei;Li Yiquan;Hu Ningning;Lan Tian;Zhou Ye;Li Xiao;Sun Lili;Jin Ningyi;Department of Preventive Veterinary Medicine;College of Veterinary Medicine;Jilin University;Department of Virus;Institute of Military Veterinary Medicine;Academy of Military Medical Sciences;Department of Laboratory Medicine;Changchun University of Chinese Medicine-Affiliated Hospital;No.1 Department of Head and Neck Surgery;Tumor Hospital of Jilin Province;
..............page:16-21
Inhibitory effect and mechanism of Bursal-derived pentapeptide-Ⅱ on tumor cell proliferation and its possible medanism
Guo Xiangling;Wang Chen;Li Xiaokang;Wang Yang;Wu Tingcai;Chen Puyan;Key Laboratory of Veterinary Oncological Immunology;Henan University of Science and Technology;Key Laboratory of Animal Bacteriology of the Ministry of Agriculture of China;Nanjing Agricultural University;
Guo Xiangling;Wang Chen;Li Xiaokang;Wang Yang;Wu Tingcai;Chen Puyan;Key Laboratory of Veterinary Oncological Immunology;Henan University of Science and Technology;Key Laboratory of Animal Bacteriology of the Ministry of Agriculture of China;Nanjing Agricultural University;
..............page:22-27
MiR-29a inhibited costimulatory molecule B7-H3 expression and the invasion of glioma growth
Gao Bing;Chen Hanqing;Shi Zhengpeng;Sun Jing;Yan Ruhong;Fu Fengqing;Zhang Xueguang;Department of Biology and Basic Medical Science;Soochow University;Institute of Medical Biotechnology;Soochow University;Suzhou Health Technology College;Department of Clinical Laboratory;Second Affiliated Hospital of Soochow University;Institute of Clinical Immunology of Jiangsu Provience;First Affiliated Hospital of Soochow University;
Gao Bing;Chen Hanqing;Shi Zhengpeng;Sun Jing;Yan Ruhong;Fu Fengqing;Zhang Xueguang;Department of Biology and Basic Medical Science;Soochow University;Institute of Medical Biotechnology;Soochow University;Suzhou Health Technology College;Department of Clinical Laboratory;Second Affiliated Hospital of Soochow University;Institute of Clinical Immunology of Jiangsu Provience;First Affiliated Hospital of Soochow University;
..............page:28-33
..............page:33
Optimized preparation of novel C-phycocyanin-carboxymethyl chitosan nanoparticles and its inhibitory effects on human cervical carcinoma He La cells proliferation
Lü Congyi;Li Bing;Yang Peng;Department of Biology;Medical College;Qingdao University;
Lü Congyi;Li Bing;Yang Peng;Department of Biology;Medical College;Qingdao University;
..............page:34-40
re lie zhu he ben kan zai ci bei ping wei rccse zhong guo quan wei xue shu qi kan
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:40
Effect of arsenic trioxide on radiosensitivity of esophageal carcinoma Eca109 cells under hypoxia
Jing Shaowu;Wang Yadi;Wang Jun;Sun Guogui;Liu Qing;Cheng Yunjie;Yang Congrong;Department of Radiotherapy;Fourth Hospital of Hebei Medical University;Department of Radiotherapy;Military General Hospital of Beijing Military Region;Department of Chemoradiotherapy;People’s Hospital of Hebei Union University;
Jing Shaowu;Wang Yadi;Wang Jun;Sun Guogui;Liu Qing;Cheng Yunjie;Yang Congrong;Department of Radiotherapy;Fourth Hospital of Hebei Medical University;Department of Radiotherapy;Military General Hospital of Beijing Military Region;Department of Chemoradiotherapy;People’s Hospital of Hebei Union University;
..............page:41-46
gan rao su xia you fen zi 25- zuo ji dan gu chun yi zhi il-1 you dao chan sheng de yan zheng
chen kun ; liu shu xun ;andrea r;dang ev;jeffrey g;
chen kun ; liu shu xun ;andrea r;dang ev;jeffrey g;
..............page:46
Gamma-secretase inhibitor-induced B lymphoma cell apoptosis
Zhang Shuangfeng;Yang Lujun;Teng Rong;You Xuefen;Shi Wenyu;Department of Hematology;Medical College of Nantong University;Department of Hematology;Yixing People’s Hospital;Department of Hematology;Affiliated Hospital of Natong University;
Zhang Shuangfeng;Yang Lujun;Teng Rong;You Xuefen;Shi Wenyu;Department of Hematology;Medical College of Nantong University;Department of Hematology;Yixing People’s Hospital;Department of Hematology;Affiliated Hospital of Natong University;
..............page:47-51
Effects of estrogen receptor β on resistance to tamoxifen-based endocrine therapy of human breast cancer
Wei Li;Duan Hongjie;Niu Xiulong;Liu Wenxing;Deng Weimin;Department of Immunology;Basic Medical Colloge;Tianjin Medical University;Department of Infectious Diseases;Affiliated Hospital of Logistics University of People’s Armed Police Forces;
Wei Li;Duan Hongjie;Niu Xiulong;Liu Wenxing;Deng Weimin;Department of Immunology;Basic Medical Colloge;Tianjin Medical University;Department of Infectious Diseases;Affiliated Hospital of Logistics University of People’s Armed Police Forces;
..............page:52-56
Inhibitory effect of polyamidoamine dendrimer-CXCR4-shRNA nanoparticles on the proliferation of renal carcinoma cells
Dong qin;Ye Chunlin;Gao Feng;Cui Jie;Chen Pei;Wang Shaoliang;Cai Chen;Department of nephrology;Shanghai Municipal Corps Hospital;People’s Armed Police Forces;Department of Special Diagnoses;Changhai Hospital;Second Military Medical University;
Dong qin;Ye Chunlin;Gao Feng;Cui Jie;Chen Pei;Wang Shaoliang;Cai Chen;Department of nephrology;Shanghai Municipal Corps Hospital;People’s Armed Police Forces;Department of Special Diagnoses;Changhai Hospital;Second Military Medical University;
..............page:57-61
Phosphoinositide-3 catalytic subunit delta in gastric cancer: possible correlations with clinicopathologic characteristics and prognosis
Qiao Shifeng;Li Shizheng;Tong Xin;Department of General Surgery;First Affiliated Hospital of Liaoning Medical University;
Qiao Shifeng;Li Shizheng;Tong Xin;Department of General Surgery;First Affiliated Hospital of Liaoning Medical University;
..............page:62-66
Influence of Helicobacter pylori infection on autologous DC-CIK maintenance therapy in the advanced gastric cancer patients
Ding Yuan;Chen Yuqiang;Li Qiaozhen;Mi Yan Jun;Yan Jianghua;Ye Yanhua;Department of Oncology;No.174 Hospital of PLA;Cancer Research Center;Medical College of Xiamen University;
Ding Yuan;Chen Yuqiang;Li Qiaozhen;Mi Yan Jun;Yan Jianghua;Ye Yanhua;Department of Oncology;No.174 Hospital of PLA;Cancer Research Center;Medical College of Xiamen University;
..............page:67-72
gu you lin ba xi bao ying xiang chang dao wen tai
hu xiang ; han chao feng ;mortha a;chudnovskiy a;hashimoto d;
hu xiang ; han chao feng ;mortha a;chudnovskiy a;hashimoto d;
..............page:72
A novel transient receptor potential calcium channel subfamily V member 6(TRPV6):Its expression and clinical significance in stomach cancer
Zhong Xiaomin;He Jingdong;Chen Xiaofei;Yu Xiaojuan;Department of Medical Oncology;Nanjing Medical University-Afiliated Huaian First People’s Hospital;
Zhong Xiaomin;He Jingdong;Chen Xiaofei;Yu Xiaojuan;Department of Medical Oncology;Nanjing Medical University-Afiliated Huaian First People’s Hospital;
..............page:73-78
cao xue tao yuan shi ke yan tuan dui cheng guo fa biao yu guo ji ding jian za zhi bing ru xuan 2014 nian du zhong guo gao deng xue xiao shi da ke ji jin zhan
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:78
ben kan zhu bian cao xue tao yuan shi ji qi ke yan tuan dui cheng guo rong huo 2014 nian du zhong hua yi xue ke ji yi deng jiang
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:78
Changes in Treg cells and their cytokine production in the peripheral blood of gastric cancer patients following immunotherapy with DC-CIK cells
Sun Weihong;Wei Xiaofang;Zhao Peng;Li Changyou;Gao Daiqing;Biotherapy Center;Qingdao Center Hospital;
Sun Weihong;Wei Xiaofang;Zhao Peng;Li Changyou;Gao Daiqing;Biotherapy Center;Qingdao Center Hospital;
..............page:79-83
cao xue tao yuan shi rong zuo 2014 nian zhong guo ke xue nian du xin wen ren wu cheng hao
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:83
Immune function and life quality in patients with advanced non-small cell lung cancer following treatment with autologous cytokine-induced killer cells
Zhu Ting;Jiang Beilei;Jiang Qian;Li Yuzhi;Bao Yangyi;Department of Oncology;First People’s Hospital of Hefei;
Zhu Ting;Jiang Beilei;Jiang Qian;Li Yuzhi;Bao Yangyi;Department of Oncology;First People’s Hospital of Hefei;
..............page:84-88
..............page:88
PersonGenTM versus CIK induction techniques in the expansion and activation of human T cells
Zhou Ruyuan;Zuo Qiaozhu;Ye Sisi;Zong Yunhui;LI Yafen;Chen Dan;Yang Lin;Soochow University Cyrus Tang Hematology Center;PersonGen Biomedicine Co. Ltd.;
Zhou Ruyuan;Zuo Qiaozhu;Ye Sisi;Zong Yunhui;LI Yafen;Chen Dan;Yang Lin;Soochow University Cyrus Tang Hematology Center;PersonGen Biomedicine Co. Ltd.;
..............page:89-95
cao xue tao yuan shi rong zuo zhong guo zui niu bo dao gui guan
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:95
IL-22 and IL-17 mRNA expression and clinical significance in PBMC in patients with hepatocellular carcinoma
chen hong tao ; yang zhi ; wu shi pin ;
chen hong tao ; yang zhi ; wu shi pin ;
..............page:96-98
CD19 and immunotherapy of B-cell lineage malignancies
liu ya dan ; wu ; han shuang yin ;
liu ya dan ; wu ; han shuang yin ;
..............page:99-103
trib1 zai zu zhi ding ju m2 xing ju shi xi bao de fa yu guo cheng zhong fa hui zhong yao zuo yong
zhang xiang ; han yan mei ;satoh t;kidoya h;naito h;
zhang xiang ; han yan mei ;satoh t;kidoya h;naito h;
..............page:103
Current advances in basic and clinical study of NY-ESO-1
yu zuo jun ; wan tao ;
yu zuo jun ; wan tao ;
..............page:104-111
cao xue tao yuan shi ke yan jiao xue tuan dui rong zuo zhong guo yan jiu sheng jiao yu cheng guo te deng jiang
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:111
Hedgehog pathway in pancreatic cancer and its cross-talk with other pathways
wang yu qiong ; gao jun ; li zhao shen ;
wang yu qiong ; gao jun ; li zhao shen ;
..............page:112-115
Telomeres and telomerase in T cells of tumor immunity
yang li li ; qian ya qin ; ren xiu bao ;
yang li li ; qian ya qin ; ren xiu bao ;
..............page:116-119
ben kan dui lun wen zhong shi yan dong wu miao shu de yao qiu
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:119
The relatimship between miR-200c and the progression of tumor
tan guo bin ; qiu ming ning ; chen he ge ; liu jian jun ;
tan guo bin ; qiu ming ning ; chen he ge ; liu jian jun ;
..............page:120-124
Therapy responses of 《Xue Fu Zhu Yu Tang》in glioma: Three cases report
lv guang mei ; wan hai jun ; zhu li ling ; qi na ; gong yong ling ;
lv guang mei ; wan hai jun ; zhu li ling ; qi na ; gong yong ling ;
..............page:125-127
wen gao zhong xu xie cheng xie ti de wai wen zi fu
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:127
..............page:128
..............page:129-130
zhi xie zhong guo zhong liu sheng wu zhi liao za zhi zu gao he shen gao zhuan jia
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:131
..............page:131-136
..............page:137-138